The clinical potential of GDF15 as a "ready-to-feed indicator" for critically ill adults.

Lisa Van DyckJan GunstMichaël P CasaerBram PeetersInge DeresePieter J WoutersFrancis de ZegherIlse VanhorebeekGreet Van den Berghe

Published in: Critical care (London, England) (2020)

ClinicalTrials.gov , NCT00512122, registered 31 July 2007, https://www.clinicaltrials.gov/ct2/show/NCT00512122 (EPaNIC trial) and ISRCTN, ISRCTN 98806770, registered 11 November 2014, http://www.isrctn.com/ISRCTN98806770 (DAS trial).

Keyphrases

phase iii
study protocol
phase ii
clinical trial
computed tomography
randomized controlled trial
open label
image quality
magnetic resonance imaging
disease activity
contrast enhanced
dual energy
magnetic resonance
human health
systemic lupus erythematosus